Rhinocerebral mucormycosis: Case report;Rinoserebral mukormikoz: Olgu sunumu

Klimik Dergisi

Volumn 24, Issue 3, 2011, Pages 191-194

  Köse, Şükran ^a   Gül, Selma ^a   Akkoçlu, Gülgün ^a   Türken, Melda ^a   Inci, Ramazan ^b  

^a Infeksiyon Hastaliklari ve Klinik Mikrobiyoloji Klini i   (Turkey)

^b EGE UNIVERSITY   (Turkey)

Author keywords

Diabetes mellitus; Rhinocerebral mucormycosis; Rhizopus oryzae

Indexed keywords

ANTIFUNGAL AGENT;

AGED; ANOREXIA; ARTICLE; CASE REPORT; DEBRIDEMENT; DIABETES MELLITUS; EARLY DIAGNOSIS; EARLY INTERVENTION; FUNGUS CULTURE; GLYCEMIC CONTROL; HEADACHE; HISTOPATHOLOGY; HUMAN; MALE; MOUTH ULCER; MUCORMYCOSIS; NEURORADIOLOGY; PHYSICAL EXAMINATION; PROGNOSIS; RESPIRATORY DISTRESS; RHINOCEREBRAL MUCORMYCOSIS; RHIZOPUS ORYZAE;

EID: 84862689660     PISSN: 1301143X     EISSN: 13091484     Source Type: Journal    
DOI: 10.5152/kd.2011.47     Document Type: Article

References (18)

1. Ener B. Mukormikoz etkenleri. In: Topçu AW, Söyletir G, Doǧanay M, eds. İnfeksiyon Hastali{dotless}klari{dotless} ve Mikrobiyolojisi. 2. baski{dotless}. İstanbul: Nobel Ti{dotless}p Kitabevleri, 2002: 1828-33.
2. Bottone EJ, Weitzman I, Hanna BA. Rhizopus rhizopodiformis: emerging etiological agent of mucormycosis. J Clin Microbiol. 1979; 9(4): 530-7.
3. Sugar AM. Agent of mucormycosis and related species. In: Mandell GL, Bennett JE, Dolin R, eds. Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases. 5th ed. New York: Churchill Livingstone, 2000: 2685-95.
4. Shi BY, Lan L, Guo H, Tan YF. Concomitant diabetic ketoacidosis and rhinocerebral mucormycosis: report of a case. Chin Med J (Engl). 2004; 117(7): 1113-5.
5. Hendrickson RG, Olshaker J, Duckett O. Rhinocerebral mucormycosis: a case of a rare, but deadly disease. J Emerg Med. 1999; 17(4): 641-5. [CrossRef]
6. Butugan O, Sanchez TG, Gonçalez F, Venosa AR, Miniti A. Rhinocerebral mucormycosis: predisposing factors, diagnosis, therapy, complications and survival. Rev Laryngol Otol Rhinol (Bord). 1996; 117(1): 53-5.
7. Sofferman RA. Cavernous sinus thrombophlebitis secondary to sphenoid sinusitis. Laryngoscope. 1983; 93(6): 797-800. [CrossRef]
8. Coşkun H, Hizalan İ, Erişen L, Basut O, Heper Y, Akalin H. Rinoserebral mukormikozis: üç olgu sunumu. Türk Otolarengol Arş. 2004; 42(1): 41-50.
9. Bouza E, Muñoz P, Guinea J. Mucormycosis: an emerging disease?. Clin Microbiol Infect. 2006; 12(Suppl. 7): 7-23. [CrossRef]
10. Hafiz G, Aktaş E, Uluǧ T, et al. Rinoserebral mukormikozis. Türk Otolarengol Arş. 1999; 37(1-2): 46-50.
11. Hilal AA, Taj-Aldeen SJ, Mirghani AH. Rhinoorbital mucormycosis secondary to Rhizopus oryzae: a case report and literature review. Ear Nose Throat J. 2004; 83(8): 556-62.
12. Feeley MA, Righi PD, Davis TE, Greist A. Mucormycosis of the paranasal sinuses and septum. Otolaryngol Head Neck Surg. 1999; 120(5): 750. [CrossRef]
13. Deboni MC, Pozzani VR, Lisboa T, Hiraki K, Viplich R, Naclério-Homem MG. Mucormycosis in an immunocompetent patient: follow-up of 1 year after treatment. Acta Otolaryngol. 2006; 126(9): 993-6. [CrossRef]
14. McDonogh M, Human P, Odendaal W. Mucorsinusitis in diabetes. S Afr Med J. 1985; 67(3): 78.
15. Ibrahim AS, Bowman JC, Avanessian V, et al. Caspofungin inhibits Rhizopus oryzae 1,3-beta-D-glucan synthase, lowers burden in brain measured by quantitative PCR, and improves survival at a low but not a high dose during murine disseminated zygomycosis. Antimicrob Agents Chemother. 2005; 49(2): 721-7. [CrossRef]
16. Chamilos G, Lewis RE, Kontoyiannis DP. Delaying amphotericin B-based frontline therapy significantly increases mortality among patients with hematologic malignancy who have zygomycosis. Clin Infect Dis. 2008; 47(4): 503-9. [CrossRef]
17. Özcan KM, Karakuş MF, Gürbüz D, Ensari S, Dere H. İnvazif fungal sinüzit: üç olgu sunumu. KBB Forum. 2008; 7(1): 31-5.
18. Kalyoncu Aslan I, Yazar T, Altin Ü, Kirbaş D. Rino-orbitoserebral mukormikoz. Türkiye Klinikleri Ti{dotless}p Bilimleri Dergisi. 2005; 25(5): 745-8.